Mina Razzak

493 citations
49 papers · 397 indexed · h-index 9
Topics
Prostate Cancer Treatment and Research (4 papers)Cancer Genomics and Diagnostics (3 papers)Bladder and Urothelial Cancer Treatments (3 papers)

In The Last Decade

Mina Razzak

46 papers receiving 392 citations

Peers

Mina Razzak
Comparison fields: 5 of 74
  • Organic Chemistry 171
  • Molecular Biology 129
  • Oncology 63
  • Biotechnology 63
  • Pharmacology 62
Replace Bruce F. Wels with:
Bruce F. Wels United States
Alison D. Findlay Australia
Steven C. Zammit Australia
Christopher F. Thompson United States
Darby Schmidt United States
Qingshou Chen United States
Bryan M. Lewis United States
Jeffery A. Zablocki United States
Bernd Buchmann Germany
S. A. PEAK United Kingdom
Mina Razzak relative to Bruce F. Wels United States Bruce F. Wels's profile →
Citations per field
00.5×1.5×2.2×
Bruce F. Wels · 1×
Citations per year

Countries citing papers authored by Mina Razzak

Since Specialization
Citations

This map shows the geographic impact of Mina Razzak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Razzak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Razzak more than expected).

Fields of papers citing papers by Mina Razzak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina Razzak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Razzak. The network helps show where Mina Razzak may publish in the future.

Co-authorship network of co-authors of Mina Razzak

This figure shows the co-authorship network connecting the top 25 collaborators of Mina Razzak. A scholar is included among the top collaborators of Mina Razzak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina Razzak. Mina Razzak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 44
5 9
6 2
7 4
8 1
9 1
10 1
11 1
12 3
13 6
14 7
15 113
16 7
17 20
18 1
19 34
20 22

About Mina Razzak

Mina Razzak is a scholar working on Developmental Biology, Oncology and Cancer Research, having authored 49 papers that have together received 397 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Cancer Genomics and Diagnostics (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Biotechnology (63 citations), Organic Chemistry (171 citations) and Pharmacology (62 citations). Mina Razzak has collaborated with scholars based in United Kingdom, United States and New Zealand. Frequent co-authors include Jef K. De Brabander, Ian Paterson, Edward A. Anderson, Peter T. Northcote, John H. Miller, Anja Wilmes, Benet Pera, Paul Teesdale‐Spittle, Mingxing Qian and Jesús Jiménez‐Barbero. Their work appears in journals such as Nature reviews. Cancer, Nature Chemical Biology and Organic Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026